Nicole Casadevall Selected Research

Erythropoietin

1/2020	The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion.
1/2020	Correction to: The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion.
1/2018	New pathogenic mechanisms induced by germline erythropoietin receptor mutations in primary erythrocytosis.
3/2015	Incidence of erythropoietin antibody-mediated pure red cell aplasia: the Prospective Immunogenicity Surveillance Registry (PRIMS).
7/2014	Rituximab in pure red-cell aplasia secondary to anti-erythropoietin antibodies.
2/2014	Risk of pure red cell aplasia in patients with hepatitis C receiving antiviral therapy and an erythropoiesis-stimulating agent.
1/2014	Genetic basis of congenital erythrocytosis: mutation update and online databases.
1/2012	Distinct deregulation of the hypoxia inducible factor by PHD2 mutants identified in germline DNA of patients with polycythemia.
1/2012	Timing and determinants of erythropoietin deficiency in chronic kidney disease.
3/2008	Early high-dose erythropoietin therapy and hypothermia after out-of-hospital cardiac arrest: a matched control study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicole Casadevall Research Topics

Disease

26	Pure Red-Cell Aplasia 03/2015 - 01/2002
19	Chronic Renal Insufficiency 01/2022 - 11/2003
17	Anemia 10/2017 - 02/2002
15	Neoplasms (Cancer) 12/2021 - 06/2004
6	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2020 - 05/2002
5	Polycythemia (Erythrocytosis) 01/2022 - 04/2005
5	Hypersensitivity (Allergy) 01/2018 - 02/2004
5	Polycythemia Vera 01/2016 - 02/2004
5	Chronic Kidney Failure (Chronic Renal Failure) 10/2005 - 01/2002
4	Myeloproliferative Disorders (Myeloproliferative Disorder) 08/2009 - 04/2005
3	Essential Thrombocythemia 01/2020 - 12/2005
3	Primary Myelofibrosis (Myelosclerosis) 01/2020 - 10/2002
3	primary familial and congenital Polycythemia 01/2018 - 01/2012
3	Lymphoma (Lymphomas) 03/2010 - 01/2002
3	Autoimmune Diseases (Autoimmune Disease) 02/2007 - 01/2002
2	Neutropenia 04/2014 - 02/2007
2	Drug-Related Side Effects and Adverse Reactions 04/2014 - 11/2005
2	Hypoxia (Hypoxemia) 01/2014 - 01/2012
1	IGA Glomerulonephritis (IGA Nephropathy) 01/2022
1	Kidney Diseases (Kidney Disease) 01/2022
1	Thrombosis (Thrombus) 01/2017
1	Infections 04/2014
1	Hepatitis C 02/2014
1	Iron Deficiencies 01/2012
1	Extra-Adrenal Paraganglioma (Paraganglioma, Extra Adrenal) 01/2012
1	Obesity 01/2012
1	Body Weight (Weight, Body) 11/2009
1	Hypothermia 03/2008
1	Out-of-Hospital Cardiac Arrest 03/2008
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2006
1	Septic Shock (Toxic Shock Syndrome) 07/2006
1	Disease Progression 06/2006
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2005
1	Hematologic Diseases (Blood Diseases) 10/2005
1	Splenomegaly 05/2005

Drug/Important Bio-Agent (IBA)

34	Erythropoietin FDA Link 01/2020 - 01/2002
17	AntibodiesIBA 07/2014 - 02/2002
11	HematinicsIBA 02/2014 - 05/2005
10	Epoetin Alfa (Epogen)FDA Link 10/2017 - 05/2004
4	Hemoglobins (Hemoglobin)IBA 01/2022 - 01/2005
4	CalreticulinIBA 12/2021 - 01/2016
4	Biological ProductsIBA 01/2020 - 02/2004
3	Peptides (Polypeptides)IBA 01/2018 - 08/2007
3	Erythropoietin Receptors (Erythropoietin Receptor)IBA 01/2018 - 07/2008
3	Rituximab (Mabthera)FDA Link 07/2014 - 01/2002
3	Proteins (Proteins, Gene)FDA Link 04/2012 - 01/2008
3	Janus Kinase 2IBA 08/2009 - 06/2006
3	epoetin betaIBA 07/2009 - 09/2004
3	CytokinesIBA 10/2005 - 02/2004
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2005 - 05/2002
2	Thrombopoietin ReceptorsIBA 12/2021 - 01/2016
2	Amino Acids FDA Link 01/2018 - 04/2005
2	DNA (Deoxyribonucleic Acid)IBA 01/2012 - 09/2011
2	hematideIBA 11/2009 - 08/2007
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2005 - 10/2005
2	Tyrosine (L-Tyrosine)FDA Link 10/2005 - 04/2005
2	Pharmaceutical PreparationsIBA 09/2004 - 11/2003
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 07/2004 - 05/2002
2	Neutralizing AntibodiesIBA 05/2004 - 02/2002
1	Immunoglobulin A (IgA)IBA 01/2022
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2016
1	Thrombopoietin (c-mpl Ligand)IBA 01/2016
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 04/2014
1	AutoantibodiesIBA 04/2014
1	InterferonsIBA 02/2014
1	Antiviral Agents (Antivirals)IBA 02/2014
1	Ribavirin (Virazole)FDA LinkGeneric 02/2014
1	Immunoglobulins (Immunoglobulin)IBA 02/2014
1	Oxygen (Dioxygen)IBA 01/2014
1	2,3-Diphosphoglycerate (2,3 Bisphosphoglycerate)IBA 01/2014
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2012
1	Arginine (L-Arginine)FDA Link 01/2012
1	C-Reactive ProteinIBA 01/2012
1	5-hydroxymethylcytosineIBA 09/2011
1	5-Methylcytosine (5 Methylcytosine)IBA 09/2011
1	Human Serum Albumin FDA LinkGeneric 08/2008
1	IronIBA 03/2008
1	Neuroprotective AgentsIBA 03/2008
1	Fas Ligand Protein (Fas Ligand)IBA 02/2007
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 12/2006
1	Darbepoetin alfa (Aranesp)FDA Link 10/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2006
1	Arsenic Trioxide (Trisenox)FDA Link 06/2006
1	Oncogene Proteins (Oncogene Protein)IBA 12/2005
1	6-pyruvoyltetrahydropterin synthase (PTPS)IBA 10/2005
1	Phosphotransferases (Kinase)IBA 10/2005
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 10/2005
1	EnzymesIBA 10/2005
1	Phenylalanine (L-Phenylalanine)FDA Link 04/2005
1	Valine (L-Valine)FDA Link 04/2005
1	Recombinant DNA (Recombinant DNA Research)IBA 01/2005

Therapy/Procedure

9	Therapeutics 02/2014 - 07/2004
3	Kidney Transplantation 04/2014 - 02/2004
2	Injections 03/2008 - 05/2005
2	Radiotherapy 03/2008 - 06/2004
2	Erythrocyte Transfusion 05/2002 - 01/2002
1	Drug Therapy (Chemotherapy) 03/2010
1	Subcutaneous Injections 11/2009
1	Transplantation 05/2009
1	Resuscitation 03/2008